IBJNews

Lilly stock shrugs off analyst downgrade

Back to TopCommentsE-mailPrintBookmark and Share

Shares of Eli Lilly and Co. slipped only slightly Friday in premarket trading after an analyst lowered his rating on the shares, calling them "our least preferred US stock."

The Indianapolis-based drugmaker has become too reliant on its remaining pipeline of drugs under development for growth as it deals with patent expirations to big sellers and some drug-development setbacks, Jefferies analyst Jeffrey Holford said in a Friday morning research report.

"We are also skeptical of many of the remaining pipeline assets," he wrote.

Holford lowered his rating on the stock to "underperform" from "hold" and dropped his price target on the shares to $40 from $49.

He also said he expects increasing competition and slower sales volume from the U.S. diabetes market, which is a big source of revenue for Lilly, and he noted that drug companies in general face challenges from unfavorable foreign exchange rates and pricing pressure in Europe.

Lilly shares fell 45 cents, to $48.70 each, in premarket trading about 30 minutes ahead of the market opening. The stock has traded between $44.88 and $58.40 over the past year. It hovered around the same mark in early trading after the market opened.

An Eli Lilly spokesman declined to comment on the report.

Lilly will lose the patent protecting its top-selling drug, the antidepressant Cymbalta, from cheaper generic competition at the end of this year. It's already dealing with a revenue hit from the 2011 U.S. patent expiration for the anti-psychotic Zyprexa, the company's all-time best-selling drug.

The company said late last month that it no longer plans to seek regulatory approval for the drug ramucirumab to treat patients with a form of breast cancer that has spread. However, Lilly is studying the drug in other uses and will seek approval to use the treatment in combination with chemotherapy in stomach cancer patients.

The drugmaker said last week that it has 13 potential drugs in late-stage clinical development, or the final phase before a company seeks regulatory approval. Next year, it could launch a couple diabetes treatments and ramucirumab.

But Lilly also told investors and analysts that foreign exchange rates and slower growth in some markets will make it challenging for the company to meet its 2014 revenue goal.

 

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. Why not take some time to do some research before traveling to that Indiana town or city, and find the ones that are no smoking either inside, or have a patio? People like yourself are just being selfish, and unnecessarily trying to take away all indoor venues that smokers can enjoy themselves at. Last time I checked, it is still a free country, and businesses do respond to market pressure and will ban smoking, if there's enough demand by customers for it(i.e. Linebacker Lounge in South Bend, and Rack and Helen's in New Haven, IN, outside of Fort Wayne). Indiana law already unnecessarily forced restaurants with a bar area to be no smoking, so why not support those restaurants that were forced to ban smoking against their will? Also, I'm always surprised at the number of bars that chose to ban smoking on their own, in non-ban parts of Indiana I'll sometimes travel into. Whiting, IN(just southeast of Chicago) has at least a few bars that went no smoking on their own accord, and despite no selfish government ban forcing those bars to make that move against their will! I'd much rather have a balance of both smoking and non-smoking bars, rather than a complete bar smoking ban that'll only force more bars to close their doors. And besides IMO, there are much worser things to worry about, than cigarette smoke inside a bar. If you feel a bar is too smoky, then simply walk out and take your business to a different bar!

  2. As other states are realizing the harm in jailing offenders of marijuana...Indiana steps backwards into the script of Reefer Madness. Well...you guys voted for your Gov...up to you to vote him out. Signed, Citizen of Florida...the next state to have medical marijuana.

  3. It's empowering for this niche community to know that they have an advocate on their side in case things go awry. http://www.youtube.com/watch?v=Lrst9VXVKfE

  4. Apparently the settlement over Angie's List "bundling" charges hasn't stopped the practice! My membership is up for renewal, and I'm on my third email trying to get a "basic" membership rather than the "bundled" version they're trying to charge me for. Frustrating!!

  5. Well....as a vendor to both of these builders I guess I have the right to comment. Davis closed his doors with integrity.He paid me every penny he owed me. Estridge,STILL owes me thousands and thousands of dollars. The last few years of my life have been spent working 2 jobs, paying off the suppliers I used to work on Estridge jobs and just struggling to survive. Shame on you Paul...and shame on you IBJ! Maybe you should have contacted the hundreds of vendors that Paul stiffed. I'm sure your "rises from the ashes" spin on reporting would have contained true stories of real people who have struggled to find work and pay of their debts (something that Paul didn't even attempt to do).

ADVERTISEMENT